Juxtamembrane region of the amino terminus of the corticotropin releasing factor receptor type 1 is important for ligand interaction

被引:28
作者
Assil, IQ
Qi, LJ
Arai, M
Shomali, M
Abou-Samra, AB [1 ]
机构
[1] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
关键词
D O I
10.1021/bi001758y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The functional properties of the amino terminus (NT) of the corticotropin releasing factor (CRF) receptor type 1 (R1) were studied by use of murine (m) CRFR1 and rat (r) parathyroid hormone (PTH)/parathyroid hormone-related peptide receptor (PTH1R) chimeras. The chimeric receptor CXP, in which the NT of mCRFR1 was annealed to the TMs of PTH1R, and the reciprocal hybrid, PXC, bound radiolabeled analogues of sauvagine and PTH(3-34), respectively. Neither hybrid bound radiolabeled CRF or PTH(1-34). CRF and PTH(1-34) weakly stimulated intracellular cAMP accumulation in COS-7 cells transfected with PXC and CXP, respectively. Thus the NT is required for ligand binding and the TMs are required for agonist-stimulated cAMP accumulation. Replacing individual intercysteine segments of PXC with their mCRFR1 counterparts did not rescue CRF or sauvagine radioligand binding or stimulation of cAMP accumulation. Replacement of residues 1-31 of mCRFR1 with their PTH1R counterparts resulted in a chimeric receptor, PEG, which had normal CRFR1 functional properties. In addition, a series of chimeras (F1PEC-F6PEC) were generated by replacement of the NT intercysteine residues of PEC with their PTH1R counterparts. Only F1PEC, F2PEC, and F3PEC showed detectable CRF and sauvagine radioligand binding. All of the PEC chimeras except F5PEC increased cAMP accumulation. These data indicate that the Cys(68-)Glu(109) domain is important for binding and that the Cys(87)-Cys(102) region plays an important role in CRFR1 activation.
引用
收藏
页码:1187 / 1195
页数:9
相关论文
共 44 条
  • [1] MECHANISMS OF ACTION OF CRF AND OTHER REGULATORS OF ACTH RELEASE IN PITUITARY CORTICOTROPHS
    ABOUSAMRA, AB
    HARWOOD, JP
    CATT, KJ
    AGUILERA, G
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 512 : 67 - 84
  • [2] The role of corticotropin-releasing factor in depression and anxiety disorders
    Arborelius, L
    Owens, MJ
    Plotsky, PM
    Nemeroff, CB
    [J]. JOURNAL OF ENDOCRINOLOGY, 1999, 160 (01) : 1 - 12
  • [3] SYNTHESIS AND SUPERCONDUCTIVITY OF A NEW 1222-TYPE T1-BASED LAYERED CUPRATE (T1, NB) SR2(ND, CE)2CU2OZ
    CHEN, ZY
    TANG, YQ
    LI, YF
    PEDERSON, DO
    SHENG, ZZ
    [J]. ZEITSCHRIFT FUR PHYSIK B-CONDENSED MATTER, 1993, 90 (01): : 19 - 22
  • [4] Dautzenberg FM, 1997, J NEUROCHEM, V69, P1640
  • [5] Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1:: Implications for the ligand-binding site
    Dautzenberg, FM
    Wille, S
    Lohmann, R
    Spiess, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) : 4941 - 4946
  • [6] The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: Generation of chimeric receptors with a novel ligand-selective profile
    Dautzenberg, FM
    Kilpatrick, GJ
    Wille, S
    Hauger, RL
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 73 (02) : 821 - 829
  • [7] Cloning and characterization of human urocortin
    Donaldson, CJ
    Sutton, SW
    Perrin, MH
    Corrigan, AZ
    Lewis, KA
    Rivier, JE
    Vaughan, JM
    Vale, WW
    [J]. ENDOCRINOLOGY, 1996, 137 (05) : 2167 - 2170
  • [8] The luteinizing hormone receptor
    Dufau, ML
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1998, 60 : 461 - 496
  • [9] Transmembrane residues of the parathyroid hormone (PTH)/PTH-related peptide receptor that specifically affect binding and signaling by agonist ligands
    Gardella, TJ
    Luck, MD
    Fan, MH
    Lee, CW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) : 12820 - 12825
  • [10] Structure-activity studies on 4-substituted-2-anilinopyrimidine corticotropin releasing factor (CRF) antagonists
    Gilligan, PJ
    He, LQ
    Culp, S
    Fitzgerald, L
    Tam, SW
    Wong, YN
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (11) : 2321 - 2328